Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Aclaris Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +31 vs. Q1 2021
- Shares held
- 56.0M
- +10.6M (+23.3%) vs. Q1 2021
- Total value
- $983.4M
- −$161.4M (−14.1%) vs. Q1 2021
- New holders
- 49
- 34 more added
- Sold out
- 18
- 32 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Metropolitan Life Insurance Co | 12,696 | $222.9K | 0.00% | +12,696 | New |
| Twin Securities, Inc. | 12,500 | $220.0K | 0.08% | +12,500 | New |
| Baker Tilly Wealth Management, LLC | 11,739 | $206.0K | 0.03% | 00.0% | Unchanged |
| Barclays PLC | 11,767 | $205.0K | 0.00% | +11,749+65,272.2% | Added |
| ProShare Advisors LLC | 11,264 | $198.0K | 0.00% | +11,264 | New |
| Citigroup Inc | 9,013 | $158.0K | 0.00% | +2,840+46.0% | Added |
| Tower Research Capital LLC (TRC) | 8,457 | $149.0K | 0.00% | +7,766+1,123.9% | Added |
| Legal & General Group Plc | 6,172 | $109.0K | 0.00% | +6,172 | New |
| First Mercantile Trust Co | 4,712 | $83.0K | 0.01% | +4,712 | New |
| Simplex Trading, LLC | 4,539 | $79.0K | 0.00% | −9,434−67.5% | Reduced |
| Ameritas Investment Partners, Inc. | 3,404 | $60.0K | 0.00% | +3,404 | New |
| Advisor Group Holdings, Inc. | 3,195 | $56.0K | 0.00% | +300+10.4% | Added |
| Royal Bank of Canada | 2,974 | $52.0K | 0.00% | −541−15.4% | Reduced |
| UBS Group AG | 2,899 | $51.0K | 0.00% | −3,467−54.5% | Reduced |
| Brown Brothers Harriman & Co | 2,588 | $45.0K | 0.00% | +2,588 | New |
| Point72 Hong Kong Ltd | 2,378 | $42.0K | 0.00% | +2,378 | New |
| Great West Life Assurance Co | 1,944 | $34.0K | 0.00% | +1,944 | New |
| Group One Trading, L.P. | 1,769 | $31.0K | 0.00% | −14,380−89.0% | Reduced |
| BNP Paribas Arbitrage, SA | 1,656 | $29.1K | 0.00% | +1,656 | New |
| Wells Fargo & Company | 1,111 | $20.0K | 0.00% | −279−20.1% | Reduced |
| Panagora Asset Management Inc | 749 | $13.0K | 0.00% | −25−3.2% | Reduced |
| Cutler Group LP | 600 | $10.0K | 0.00% | −2,300−79.3% | Reduced |
| Northwestern Mutual Wealth Management Co | 500 | $9.00K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 323 | $6.00K | 0.00% | −1,391−81.2% | Reduced |
| Brewin Dolphin Ltd | 195 | $3.42K | 0.00% | +195 | New |
| Truvestments Capital LLC | 150 | $3.00K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 100 | $2.00K | 0.00% | −1,100−91.7% | Reduced |
| Harbour Investments, Inc. | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Stenahm Asset Managment Ltd | 0 | $0 | 0.00% | −283,500−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −205,295−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −175,799−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −164,199−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −152,119−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −121,563−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −84,276−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −36,612−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −26,974−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −24,302−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −17,740−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −16,473−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −11,038−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −8,537−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −6,110−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −2,605−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −291−100.0% | Sold out |